Regeneron Pharmaceuticals Gross Profit 2010-2024 | REGN
- Regeneron Pharmaceuticals annual gross profit for 2023 was $11.301B, a 6.49% increase from 2022.
- Regeneron Pharmaceuticals annual gross profit for 2022 was $10.613B, a 22.16% decline from 2021.
- Regeneron Pharmaceuticals annual gross profit for 2021 was $13.634B, a 84.82% increase from 2020.